On November 6, Palantir rises 3.38% in Pre-Market Trading, trading at $160.25 per share, with turnover of $13.7415 million.
The latest catalyst was event-driven: reports said the UK plans to extend Palantir's NHS contract while also preparing potential alternatives, and the company separately said it will expand AI capabilities across AmeriLife's business workflows in the coming months.
These updates arrive after a volatile post-earnings stretch for the stock. Earlier disclosures showed Palantir reported third-quarter revenue of $2.313 billion and adjusted EPS of $0.44, both above expectations, while raising fourth-quarter and full-year revenue guidance. Even so, recent trading had been pressured by concerns over flat remaining performance obligations, softer order-related indicators, and heavy bearish options activity, including a $22.94 million same-direction double long put structure highlighted on November 6.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments